Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Bacteriophages in Natural and Artificial Environments.

Batinovic S, Wassef F, Knowler SA, Rice DTF, Stanton CR, Rose J, Tucci J, Nittami T, Vinh A, Drummond GR, Sobey CG, Chan HT, Seviour RJ, Petrovski S, Franks AE.

Pathogens. 2019 Jul 12;8(3). pii: E100. doi: 10.3390/pathogens8030100. Review.

2.

Genomic, morphological and functional characterisation of novel bacteriophage FNU1 capable of disrupting Fusobacterium nucleatum biofilms.

Kabwe M, Brown TL, Dashper S, Speirs L, Ku H, Petrovski S, Chan HT, Lock P, Tucci J.

Sci Rep. 2019 Jun 24;9(1):9107. doi: 10.1038/s41598-019-45549-6.

3.

No evidence for widespread Babesia microti transmission in Australia.

Faddy HM, Rooks KM, Irwin PJ, Viennet E, Paparini A, Seed CR, Stramer SL, Harley RJ, Chan HT, Dennington PM, Flower RLP.

Transfusion. 2019 Jul;59(7):2368-2374. doi: 10.1111/trf.15336. Epub 2019 May 9.

PMID:
31070793
4.

Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.

Douglas AP, Marshall C, Baines SL, Ritchie D, Szer J, Madigan V, Chan HT, Ballard SA, Howden BP, Buising K, Slavin MA.

J Med Microbiol. 2019 Mar;68(3):303-308. doi: 10.1099/jmm.0.000916. Epub 2019 Jan 21.

PMID:
30663951
5.

Health service impact of testing for respiratory pathogens using cartridge-based multiplex array versus molecular batch testing.

Madigan VM, Sinickas VG, Giltrap D, Kyriakou P, Ryan K, Chan HT, Clifford V.

Pathology. 2018 Dec;50(7):758-763. doi: 10.1016/j.pathol.2018.08.012. Epub 2018 Oct 30.

PMID:
30389216
6.

Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia.

Brown TL, Petrovski S, Chan HT, Angove MJ, Tucci J.

Pharmaceuticals (Basel). 2018 Feb 26;11(1). pii: E26. doi: 10.3390/ph11010026. Review.

7.

Ross River virus in Australian blood donors: possible implications for blood transfusion safety.

Faddy HM, Tran TV, Hoad VC, Seed CR, Viennet E, Chan HT, Harley R, Hewlett E, Hall RA, Bielefeldt-Ohmann H, Flower RLP, Prow NA.

Transfusion. 2018 Feb;58(2):485-492. doi: 10.1111/trf.14472. Epub 2018 Jan 19.

PMID:
29350414
8.

Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca.

Brown TL, Petrovski S, Hoyle D, Chan HT, Lock P, Tucci J.

PLoS One. 2017 Aug 17;12(8):e0183510. doi: 10.1371/journal.pone.0183510. eCollection 2017.

9.

Hepatitis E virus RNA in Australian blood donations.

Shrestha AC, Flower RL, Seed CR, Keller AJ, Harley R, Chan HT, Hoad V, Warrilow D, Northill J, Holmberg JA, Faddy HM.

Transfusion. 2016 Dec;56(12):3086-3093. doi: 10.1111/trf.13799. Epub 2016 Sep 25.

PMID:
27667133
10.

The infectious disease blood safety risk of Australian hemochromatosis donations.

Hoad V, Bentley P, Bell B, Pathak P, Chan HT, Keller A.

Transfusion. 2016 Dec;56(12):2934-2940. doi: 10.1111/trf.13802. Epub 2016 Sep 23.

PMID:
27662424
11.

Hepatitis E virus and implications for blood supply safety, Australia.

Shrestha AC, Seed CR, Flower RL, Rooks KM, Keller AJ, Harley RJ, Chan HT, Holmberg JA, Faddy HM.

Emerg Infect Dis. 2014 Nov;20(11):1940-2. doi: 10.3201/eid2011.140412. No abstract available.

12.

Case cluster of necrotizing fasciitis and cellulitis associated with vein sclerotherapy.

Chan HT, Low J, Wilson L, Harris OC, Cheng AC, Athan E.

Emerg Infect Dis. 2008 Jan;14(1):180-1. doi: 10.3201/eid1401.070250. No abstract available.

13.

Phagocytic efficiency of monocytes and macrophages obtained from Sydney blood bank cohort members infected with an attenuated strain of HIV-1.

Kedzierska K, Churchill M, Maslin CL, Azzam R, Ellery P, Chan HT, Wilson J, Deacon NJ, Jaworowski A, Crowe SM.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):445-53.

PMID:
14657753

Supplemental Content

Loading ...
Support Center